391 filings
Page 3 of 20
8-K
6bciszvni8 v7kjpf
16 Feb 23
PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
4:07pm
8-K
anzq4hqq
27 Jan 23
Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock
4:05pm
424B5
unxajkdd
25 Jan 23
Prospectus supplement for primary offering
6:02am
424B5
xn6thw
24 Jan 23
Prospectus supplement for primary offering
5:12pm
8-K
dnji185da
24 Jan 23
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
4:43pm
8-K
1kxc2gq4gjjr247i vcz
9 Jan 23
PacBio Announces Record Orders, Including Orders for 76 Revio Systems Received in the Fourth Quarter of 2022
7:41am
8-K
m84djgu
7 Nov 22
PacBio Announces Third Quarter 2022 Financial Results
4:23pm
8-K
6sahpn m0k5rqvw7
25 Oct 22
Withdraws Guidance with New Product Announcement
9:05pm
8-K
nyiztii1
3 Aug 22
PacBio Announces Second Quarter 2022 Financial Results
4:44pm
8-K
aex04
30 Jun 22
Entry into a Material Definitive Agreement
4:05pm
EFFECT
kb16qaox 0or54
1 Jun 22
Notice of effectiveness
12:15am
S-8
4hyyrwm7 o09u
26 May 22
Registration of securities for employees
5:28pm
8-K
avp970bo5xt4
26 May 22
Departure of Directors or Certain Officers
4:23pm
POS AM
dvjoxei 3w
26 May 22
Prospectus update (post-effective amendment)
4:07pm
SD
spjha64xdri1x371ku
25 May 22
Conflict minerals disclosure
3:29pm
DEFA14A
icr8b6im0axetd
24 May 22
Additional proxy soliciting materials
8:00am
8-K
peunfyokc
17 May 22
Departure of Directors or Certain Officers
4:01pm
DEFA14A
fym pxo630bb48
9 May 22
Additional proxy soliciting materials
12:00am